Eli Lilly and Company (LLY) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Eli Lilly and Company (LLY) - Medical Equipment - Deals and Alliances Profile

Eli Lilly and Company (LLY) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Eli Lilly and Company (LLY) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
82 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It also provides pet medicine, food-safety products and companion animal health products, besides services to the food animal industry. Lilly also has mid-to-late stage pipeline portfolio for conditions such as diabetes, cancer, neurological problems and autoimmune disorders. The company distributes human pharmaceutical and animal health products through independent wholesale distributors.

Eli Lilly and Company (LLY) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detai

  
Source:
Document ID
GDME4003D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Eli Lilly and Company, Medical Equipment, Deals By Year, 2010 to YTD 201652
Eli Lilly and Company, Medical Equipment Deals By Type, 2010 to YTD 201671
Eli Lilly and Company, Medical Equipment, Deals By Region, 2010 to YTD 201681
Eli Lilly and Company, Medical Equipment, Deals By Market, 2010 to YTD 201691
Eli Lilly and Company, Medical Equipment, Deals Summary, 2010 to YTD 2016102
Eli Lilly and Company, Medical Equipment, Deal Details1223
  Asset Purchase121
    Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions122
  Venture Financing141
    Millin Enterprises Raises Funds through Series A financing141
    ACEA Biosciences Raises USD30 Million in Venture Financing151
    Veritas Genetics Raises USD10 Million in Series A Financing Round161
    Companion Medical Raises USD3.15 Million in Series B Financing171
  Partnerships181
    Insulet Enters into Co-Development Agreement with Eli Lilly181
    Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test191
    Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test201
    Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker211
    Corgenix Enters Into Co-Development Agreement With Eli Lilly221
    Insulet Enters Into Co-Development Agreement With Eli Lilly231
    Qiagen Enters Into Co-Development Agreement With Eli Lilly241
    Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests251
    PrimeraDx Enters Into Co-Development Agreement With Eli Lilly261
    Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid271
    PETNET Solutions Enters Into Distribution Agreement With Eli Lilly and Company281
    QIAGEN Enters Into Co-Development Agreement With Eli Lilly291
    Synthes Enters Into Co-Development Agreement With Eli Lilly301
    Eli Lilly Enters Into Collaboration With Medtronic311
  Acquisition321
    Eli Lilly and Company Acquires Avid RadioPharma323
Eli Lilly and Company - Key Competitors351
Key Employees362
Locations And Subsidiaries3810
  Head Office381
  Other Locations &Subsidiaries3810
Recent Developments481
Strategy And Business Planning481
Oct 07, 2015: Lilly Joins the Imaging Dementia - Evidence for Amyloid Scanning Study481
Jul 23, 2015: Eli Lilly and Company Announces Expansion of San Diego Biotechnology Center491
Financial Announcements501
Jul 26, 2016: Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Through The Remainder Of The Decade504
Apr 26, 2016: Lilly Reports First-Quarter 2016 Results, Revises 2016 Financial Guidance544
Jan 28, 2016: Lilly Reports Fourth-Quarter And Full-Year 2015 Results587
Oct 22, 2015: Lilly Reports Third-Quarter 2015 Results, Revises 2015 Financial Guidance653
Jul 23, 2015: Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance684
Corporate Communications721
Sep 14, 2016: Levi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor, M.D., Who is Retiring after a Distinguished Career721
Aug 31, 2016: Jamere Jackson Elected To Lilly Board Of Directors731
Aug 10, 2016: Lilly announces Joshua Smiley, Anat Ashkenazi appointed to new roles, Thomas Grein retires741
Jul 27, 2016: John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor752
Jun 13, 2016: Aarti Shah named chief information officer771
Dec 15, 2015: Juan R. Luciano elected to Lilly board of directors781
Other Significant Developments791
May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community792
Jul 14, 2015: Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes811
Appendix821
  Methodology821
  About GlobalData821
  Contact Us821
  Disclaimer821

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Eli Lilly and Company (LLY) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Eli-Lilly-and-Company-LLY-Medical-Equipment-Deals-and-Alliances-Profile-2148-24075>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Eli Lilly and Company (LLY) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Eli-Lilly-and-Company-LLY-Medical-Equipment-Deals-and-Alliances-Profile-2148-24075>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research